HPNE to Expand Manufacturing of Single-Use Solutions

Date Published01/20/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name HPNE
Parent companyHPNE
Type of work Manufacturing
Reshoring category:Reshoring
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2022
Domestically, the work will be done:In-house
State(s) reshored to:RI
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredBioprocess
What domestic positive factors made reshoring more attractive?Government Incentives, Biomedical Advanced Research and Development Autho
Government Incentive dollar amount:$15 million
Find Reshoring Articles